Legend Biotech Corp ADR (NASDAQ:LEGN) price on Wednesday, May 21, fall -5.79% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $28.33.
A look at the stock’s price movement, the close in the last trading session was $30.07, moving within a range at $28.14 and $31.12. The beta value (5-Year monthly) was 0.204. Turning to its 52-week performance, $60.87 and $27.34 were the 52-week high and 52-week low respectively. Overall, LEGN moved -17.84% over the past month.
Legend Biotech Corp ADR’s market cap currently stands at around $5.21 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that LEGN is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
11 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 11 recommend LEGN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
LEGN’s current price about -10.64% and -14.96% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 36.81, while 7-day volatility ratio is 6.09% and 5.53% in the 30-day chart. Further, Legend Biotech Corp ADR (LEGN) has a beta value of 0.14, and an average true range (ATR) of 1.85. Analysts have given the company’s stock an average 52-week price target of $75, forecast between a low of $75 and high of $75. Looking at the price targets, the low is -164.74% off current price level while to achieve the yearly target high, price needs to move -164.74%. Nonetheless, investors will most likely welcome a -164.74% jump to $75 which is the analysts’ median price.
If we refocus on Legend Biotech Corp ADR (NASDAQ:LEGN), historical trading data shows that trading volumes averaged 2.01 over the past 10 days and 1.46 million over the past 3 months. The company’s latest data on shares outstanding shows there are 184.03 million shares.
The 1.44% of Legend Biotech Corp ADR’s shares are in the hands of company insiders while institutional holders own 46.48% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 6.74 million on 2025-04-30, giving us a short ratio of 4.35. The data shows that as of 2025-04-30 short interest in Legend Biotech Corp ADR (LEGN) stood at 704.9999999999999 of shares outstanding, with shares short falling to 10.92 million registered in 2025-03-31. Current price change has pushed the stock -12.94% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the LEGN stock continues to rise going into the next quarter.
